Antiviral, antibacterial, and antiparasitic drugs and vaccines are essential to maintaining the
health of humans and animals. Yet, their production can be slow and expensive, and …

Antibiotic resistant bacteria are a growing threat to global health security. Whilst the
emergence of antimicrobial resistance (AMR) is a natural phenomenon, it is also driven by …

The immunoglobulin Y (IgY) derived from hyperimmune egg yolk is a promising passive
immune agent to combat microbial infections in humans and livestock. Numerous studies …

Since the discovery of antibodies by Emil Von Behring and Shibasaburo Kitasato during the
19th century, their potential for use as biotechnological reagents has been exploited in …

BACKGROUND: The emergence of novel viruses poses severe challenges to global public
health highlighting the crucial necessity for new antivirals. MAIN BODY: Monoclonal …

Safe, passive immunization methods are required against severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) and its variants. Immunization of chickens with …

Immunoglobulin yolk (IgY) is therapeutic antibodies presented in yolk eggs of birds, reptiles,
and amphibians. These proteins produced by the immune system of the animal, are capable …

Identified in 2012, the Middle East respiratory syndrome coronavirus (MERS-CoV) causes
severe and often fatal acute respiratory illness in humans. No approved prophylactic or …

Egg yolk immunoglobulin Y (IgY) is a promising class of antibodies with applications in
several areas including food safety, disease diagnosis, prevention and treatment. The …

Due to their high specificity and scalability, Monoclonal IgY antibodies have emerged as a
valuable alternative to traditional polyclonal IgY antibodies. This abstract provides an …